Frequency of NPM1 Mutation and Its Impact on Prognosis in Cytogenetically Normal AML Patients: Hyperleukocytosis Remains an Unfavorable Prognostic Marker Among NPM1 Positive Patients

Aim: Nucleophosmin 1 (NPM1) mutation is the most frequent genetic abnormality that points to a favorable prognosis in patients with cytogenetically normal acute myeloid leukemia (CN-AML). NPM1 mutation rate has not been documented yet in Turkish patients. We aimed to investigate NPM1 frequency and i...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Mehmet Sezgin Pepeler, Zübeyde Nur Özkurt, Ayşe Kaya, Sanem Gökçen, Asuman Sungurluoğlu, Handan Kayhan, Zeynep Arzu Yeğin, Münci Yağcı
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Ankara Hematology Oncology Association 2025-12-01
Ráidu:	Acta Haematologica Oncologica Turcica
Fáttát:	nmp1 flt3-itd hyperleukocytosis prognosis acute myeloid leukemia
Liŋkkat:	https://www.actaoncologicaturcica.com/articles/frequency-of-npm1-mutation-and-its-impact-on-prognosis-in-cytogenetically-normal-aml-patients-hyperleukocytosis-remains-an-unfavorable-prognostic-marker-among-npm1-positive-patients/doi/ahot.galenos.2025.2025-7-7
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!